Cargando…
A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability
BACKGROUND: As the incidence of cancer is on the rise, there is a need to develop modern communication tools between patients and the medical personnel. Electronic patient-reported outcome (ePRO) measures increase the safety of cancer treatments and may have an impact on treatment outcome as well. e...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138702/ https://www.ncbi.nlm.nih.gov/pubmed/33955841 http://dx.doi.org/10.2196/16156 |
_version_ | 1783695863859642368 |
---|---|
author | Peltola, Maria Kristiina Poikonen-Saksela, Paula Mattson, Johanna Parkkari, Timo |
author_facet | Peltola, Maria Kristiina Poikonen-Saksela, Paula Mattson, Johanna Parkkari, Timo |
author_sort | Peltola, Maria Kristiina |
collection | PubMed |
description | BACKGROUND: As the incidence of cancer is on the rise, there is a need to develop modern communication tools between patients and the medical personnel. Electronic patient-reported outcome (ePRO) measures increase the safety of cancer treatments and may have an impact on treatment outcome as well. ePRO may also provide a cost-efficient way to organize follow-up for patients with cancer. Noona is an internet-based system for patients to self-report symptoms and adverse events of cancer treatments from home via a computer or a smart device (eg, smartphone, tablet). OBJECTIVE: In this pilot study, we assessed the suitability of a novel ePRO application (Noona) for patients with cancer, nurses, and doctors at the Helsinki University Hospital, Finland. METHODS: The study included 44 patients with cancer (different solid tumor types) and 17 health care professionals (nurses or medical doctors). Patients were either operated or received systemic treatment or radiotherapy. Patients reported their symptoms to the medical staff via Noona. In addition, patients and clinicians answered a questionnaire, based on which Noona’s suitability for clinical use was evaluated in terms of usability (ease of use, operability, and learnability), reliability (subjective opinion of the participant), and incidence of harmful events reported by the participants. RESULTS: A total of 41/44 (93%) patients and 15/17 (88%) professionals reported that the program was easy or quite easy to use; 38/44 (86%) patients and 11/17 (65%) professionals found Noona reliable, and 38/44 (86%) patients and 10/17 (59%) professionals would recommend Noona to other patients or their colleagues. No harmful incidences caused by the use of Noona were reported by the patients; however, 1 harmful incidence was reported by one of the professionals. CONCLUSIONS: The majority of the participants felt that Noona appeared reliable and it was easy to use. Noona seems to be a useful tool for monitoring patient’s symptoms during cancer therapy. Future studies will determine the impact of this ePRO platform in routine clinical practice. |
format | Online Article Text |
id | pubmed-8138702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-81387022021-05-25 A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability Peltola, Maria Kristiina Poikonen-Saksela, Paula Mattson, Johanna Parkkari, Timo JMIR Form Res Original Paper BACKGROUND: As the incidence of cancer is on the rise, there is a need to develop modern communication tools between patients and the medical personnel. Electronic patient-reported outcome (ePRO) measures increase the safety of cancer treatments and may have an impact on treatment outcome as well. ePRO may also provide a cost-efficient way to organize follow-up for patients with cancer. Noona is an internet-based system for patients to self-report symptoms and adverse events of cancer treatments from home via a computer or a smart device (eg, smartphone, tablet). OBJECTIVE: In this pilot study, we assessed the suitability of a novel ePRO application (Noona) for patients with cancer, nurses, and doctors at the Helsinki University Hospital, Finland. METHODS: The study included 44 patients with cancer (different solid tumor types) and 17 health care professionals (nurses or medical doctors). Patients were either operated or received systemic treatment or radiotherapy. Patients reported their symptoms to the medical staff via Noona. In addition, patients and clinicians answered a questionnaire, based on which Noona’s suitability for clinical use was evaluated in terms of usability (ease of use, operability, and learnability), reliability (subjective opinion of the participant), and incidence of harmful events reported by the participants. RESULTS: A total of 41/44 (93%) patients and 15/17 (88%) professionals reported that the program was easy or quite easy to use; 38/44 (86%) patients and 11/17 (65%) professionals found Noona reliable, and 38/44 (86%) patients and 10/17 (59%) professionals would recommend Noona to other patients or their colleagues. No harmful incidences caused by the use of Noona were reported by the patients; however, 1 harmful incidence was reported by one of the professionals. CONCLUSIONS: The majority of the participants felt that Noona appeared reliable and it was easy to use. Noona seems to be a useful tool for monitoring patient’s symptoms during cancer therapy. Future studies will determine the impact of this ePRO platform in routine clinical practice. JMIR Publications 2021-05-06 /pmc/articles/PMC8138702/ /pubmed/33955841 http://dx.doi.org/10.2196/16156 Text en ©Maria Kristiina Peltola, Paula Poikonen-Saksela, Johanna Mattson, Timo Parkkari. Originally published in JMIR Formative Research (https://formative.jmir.org), 06.05.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Peltola, Maria Kristiina Poikonen-Saksela, Paula Mattson, Johanna Parkkari, Timo A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability |
title | A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability |
title_full | A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability |
title_fullStr | A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability |
title_full_unstemmed | A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability |
title_short | A Novel Digital Patient-Reported Outcome Platform (Noona) for Clinical Use in Patients With Cancer: Pilot Study Assessing Suitability |
title_sort | novel digital patient-reported outcome platform (noona) for clinical use in patients with cancer: pilot study assessing suitability |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138702/ https://www.ncbi.nlm.nih.gov/pubmed/33955841 http://dx.doi.org/10.2196/16156 |
work_keys_str_mv | AT peltolamariakristiina anoveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability AT poikonensakselapaula anoveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability AT mattsonjohanna anoveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability AT parkkaritimo anoveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability AT peltolamariakristiina noveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability AT poikonensakselapaula noveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability AT mattsonjohanna noveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability AT parkkaritimo noveldigitalpatientreportedoutcomeplatformnoonaforclinicaluseinpatientswithcancerpilotstudyassessingsuitability |